Put companies on watchlist
Alzchem Group AG
ISIN: DE000A2YNT30
WKN: A2YNT3
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Alzchem Group AG · ISIN: DE000A2YNT30 · EQS - Company News (86 News)
Country: Germany · Primary market: Germany · EQS NID: 2052041
16 December 2024 12:05PM

Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 2nd Interim Report


EQS-News: Alzchem Group AG / Key word(s): Share Buyback
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 2nd Interim Report

16.12.2024 / 12:05 CET/CEST
The issuer is solely responsible for the content of this announcement.


Disclosure according to Article 5 of the EU Regulation 596/2014 and

Article 2 Section (1) of the Delegated EU Regulation 2016/1052

 

 

Trostberg, December 16th, 2024

 

 

2nd Interim Report

 

In the period from December 9th up to and including December 13th, 2024, a total of 13.964  shares of Alzchem Group AG were acquired as part of the share buyback programme announced on November 5th, 2024. The total number of shares acquired to date as part of this buyback amounts to 16.301. The acquisition was carried out by a financial institution via the stock exchange (XETRA) on behalf of Alzchem Group AG.

 

The total number of repurchased shares, the weighted average price and the aggregated volume (excl. acquisition costs) per day were as follows:

 

Buyback date Total number of shares Weighted average price (EUR) Aggregated volume (EUR)
2024-12-09 2,341 59.7599 139,898.00
2024-12-10 2,711 59.9649 162,564.80
2024-12-11 2,757 57.6847 159,038.80
2024-12-12 3,089 58.4244 180,473.00
2024-12-13 3.066 58,1647 178.333,00
Σ 13.964 58,7445 820.307,60

 

This information as well as the detailed information on the individual daily transactions related to the buy-back programme are also published on the Company's website at https://www.alzchem.com/en/investor-relations/stock/#c18518 in accordance with Art. 2 par. 3 sentence 2 of Delegated Regulation (EU) 2016/1052.

 

 

Alzchem Group AG

- Managing Board -



16.12.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
Phone: +498621862888
Fax: +49862186502888
E-mail: ir@alzchem.com
Internet: www.alzchem.com
ISIN: DE000A2YNT30
WKN: A2YNT3
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
EQS News ID: 2052041

 
End of News EQS News Service

2052041  16.12.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2052041&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - Alzchem Group AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.